logo
Select company
Select metric
$ -47.9MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
13
Sector
33
Industry
48
History
22
$ 13.95Close
$ 3.59 - $ 14.97 52-Week Range
Ticker Information

Ticker

AVTX

Company Name

AVALO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AVALO THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AVTX - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 371K$ -48.27M$ -47.9M
3/31/2025$ 270K$ 69.91M$ 70.18M
12/31/2024$ 169K$ -38.33M$ -38.16M
9/30/2024$ 144K$ -10.05M$ -9.91M
6/30/2024$ 151K$ -35.78M$ -35.63M
3/31/2024$ 159K$ -140.4M$ -140.24M
12/31/2023$ 158K$ -28.11M$ -27.95M
9/30/2023$ 150K$ -28.71M$ -28.56M
6/30/2023$ 143K$ -20.95M$ -20.8M
3/31/2023$ 132K$ -25.59M$ -25.45M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AVALO THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -47.6M.
  • Over the past 5 years, AVALO THERAPEUTICS INC's average EBITDA has been $ -47.15M.
  • The median EBITDA for AVALO THERAPEUTICS INC during this period was $ -46.91M
  • AVALO THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ 70.18M.
  • The lowest EBITDA recorded by AVALO THERAPEUTICS INC in the same timeframe $ -140.24M

AVALO THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
COYA : COYA THERAPEUTICS INC $ -21.03MABVC : ABVC BIOPHARMA INC $ -2.42MVTGN : VISTAGEN THERAPEUTICS INC $ -55.12MRPTX : REPARE THERAPEUTICS INC $ -103.08MINO : INOVIO PHARMACEUTICALS INC $ -84.73MENTX : ENTERA BIO LTD $ -10.55MCOEP : COEPTIS THERAPEUTICS HOLDINGS INC $ -8.95MIBIO : IBIO INC $ -17.04MPULM : PULMATRIX INC $ -7.93MERNA : ERNEXA THERAPEUTICS INC $ -37.86M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for AVALO THERAPEUTICS INC is calculated as follows: EBIT [ $ -49.53M ] + DepAmor [ $ 1.92M ]
(=) EBITDA [ $ -47.6M ]

AVTX - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -140.24M

Minimum

Mar 31, 2024

$ 70.18M

Maximum

Mar 31, 2025

$ -47.15M

Average

$ -46.91M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M